发明名称 PHARMACEUTICAL COMPOSITION
摘要 PROBLEM TO BE SOLVED: To provide a 5-HT receptor modulator having excellent bioavailability and CNS permeability, and that is selective, highly affinitive and metabolically stable by having in vivo and excellent pharmacokinetic property.SOLUTION: The new arylpiperazinyl sulfonamide compound is represented by formula (I) [wherein Q is an alkylene amine group, or a linking group consisting of a piperidylmethyl group; Ris an alkyl group of C, a cycloalkyl group of Cor the like; Rand Rare independently hydrogen, Ccycloalkyl group or the like; m is 0, 1, 2, 3, 4, 5 or 6; n is 1, 2, 3, 4, 5 or 6; and p is 0, 1, 2, 3 or 4].
申请公布号 JP2011207904(A) 申请公布日期 2011.10.20
申请号 JP20110126287 申请日期 2011.06.06
申请人 PROXIMAGEN LTD 发明人 DHANOA DALE S;CHEN DONGLI;BECKER OREN;NOIMAN SILVIA;CHERUKU SRINIVASA RAO;MARANTZ YAEL;SHARADENDU ANURAG;SHACHEM SHARON;HEIFETZ ALEXANDER;MOHANTY PRADYUMNA;INBAL BOAZ;FICHMAN MERAV;NUDELMAN RAPHAEL;BAR-HAIM SHAY
分类号 A61K31/495;A61K31/496;A61K31/497;A61K31/506;A61K45/00;A61P15/10;A61P43/00;C07D;C07D211/26;C07D211/96;C07D213/74;C07D239/42;C07D295/12;C07D295/13;C07D401/02;C07D401/04;C07D401/12;C07D403/02 主分类号 A61K31/495
代理机构 代理人
主权项
地址